Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bundy

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cancer|July 15, 1981
Surgery for endometrial cancerG C Lewis, B Bundy
Investigational New Drugs|January 1, 1983
Phase II study of Baker's antifol (triazinate, TZT, NSC 139, 105) in advanced carcinoma of the ovary. A Gynecologic Oncology Group studyJ C Arseneau, B Bundy, H Homesley, et al.
American Journal of Clinical Oncology|August 1, 1985
Mitoxantrone (NSC 301739) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology GroupH B Muss, G P Sutton, B Bundy, et al.
American Journal of Clinical Oncology|December 1, 1984
Mitoxantrone (NSC-301739) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology GroupH B Muss, R Asbury, B Bundy, et al.
American Journal of Clinical Oncology|February 1, 1982
Phase II study of Baker's antifol (triazinate, TZT, NSC-139,105) in advanced squamous cell carcinoma of cervixJ C Arseneau, B Bundy, T Dolan, et al.
American Journal of Clinical Oncology|June 1, 1984
A phase II study of PALA (NSC 224131) in patients with advanced ovarian carcinoma. A Gynecologic Oncology Group studyH B Muss, M Slavik, B Bundy, et al.
American Journal of Clinical Oncology|December 1, 1984
PALA (NSC-224131) in advanced carcinoma of the cervix. A phase II study of the Gynecologic Oncology GroupH B Muss, B Bundy, P J DiSaia, et al.
Cancer Treatment Reports|November 1, 1979
Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group StudyR E Slayton, W T Creasman, W Petty, et al.
Gynecologic Oncology|September 1, 1984
Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study)M L Berman, H Keys, W Creasman, et al.
Cancer|September 1, 1980
Identification of breast cancer patients with high risk of early recurrence after radical mastectomy: III. Steroid hormones measured in urineA Segaloff, B F Hankey, A C Carter, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancer|July 15, 1981
Surgery for endometrial cancerG C Lewis, B Bundy
Investigational New Drugs|January 1, 1983
Phase II study of Baker's antifol (triazinate, TZT, NSC 139, 105) in advanced carcinoma of the ovary. A Gynecologic Oncology Group studyJ C Arseneau, B Bundy, H Homesley, et al.
American Journal of Clinical Oncology|August 1, 1985
Mitoxantrone (NSC 301739) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology GroupH B Muss, G P Sutton, B Bundy, et al.
American Journal of Clinical Oncology|December 1, 1984
Mitoxantrone (NSC-301739) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology GroupH B Muss, R Asbury, B Bundy, et al.
American Journal of Clinical Oncology|February 1, 1982
Phase II study of Baker's antifol (triazinate, TZT, NSC-139,105) in advanced squamous cell carcinoma of cervixJ C Arseneau, B Bundy, T Dolan, et al.
American Journal of Clinical Oncology|June 1, 1984
A phase II study of PALA (NSC 224131) in patients with advanced ovarian carcinoma. A Gynecologic Oncology Group studyH B Muss, M Slavik, B Bundy, et al.
American Journal of Clinical Oncology|December 1, 1984
PALA (NSC-224131) in advanced carcinoma of the cervix. A phase II study of the Gynecologic Oncology GroupH B Muss, B Bundy, P J DiSaia, et al.
Cancer Treatment Reports|November 1, 1979
Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group StudyR E Slayton, W T Creasman, W Petty, et al.
Gynecologic Oncology|September 1, 1984
Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study)M L Berman, H Keys, W Creasman, et al.
Cancer|September 1, 1980
Identification of breast cancer patients with high risk of early recurrence after radical mastectomy: III. Steroid hormones measured in urineA Segaloff, B F Hankey, A C Carter, et al.
Pageof 2